Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects.

导出 OA

翻译打印收藏纠错

作者： Neha,Singhal ^[1] ; V P,Praveen ^[1] ; Nisha,Bhavani ^[1] ; Arun S,Menon ^[1] ; Usha,Menon ^[1] ; Nithya,Abraham ^[1] ; Harish,Kumar ^[1] ; R V,JayKumar ^[1] ; Vasantha,Nair ^[1] ; Shanmugha,Sundaram ^[2] ; Padma,Sundaram ^[2]

作者单位： Department of Endocrine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. ^[1] Department of Nuclear Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India. ^[2]

关键词 Grave's disease relapse remission technetium scintigraphy

DOI 10.4103/2230-8210.176360

PMID 27042408

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览20

Indian journal of endocrinology and metabolism

157-61页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects.

Indian journal of endocrinology and metabolism

相似文献

Indian journal of endocrinology and metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Technetium uptake predicts remission and relapse in Grave's disease patients on antithyroid drugs for at least 1 year in South Indian subjects.

Indian journal of endocrinology and metabolism

相似文献

Indian journal of endocrinology and metabolism

相关期刊

检索历史清除